First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.
Phase 1
Completed
- Conditions
- Pulmonary Disease, Chronic ObstructiveEnterovirus InfectionsRhinovirus
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-08-23
- Last Posted Date
- 2022-03-23
- Lead Sponsor
- Curovir AB
- Target Recruit Count
- 74
- Registration Number
- NCT05016687
- Locations
- 🇸🇪
CTC Clinical Trial Consultants AB, Uppsala, Sweden
© Copyright 2025. All Rights Reserved by MedPath